Account

Background Heartbeat

Cannabis Strains in South Africa: What the Names Tell You

Macro photograph of a cannabis bud, the plant behind named cannabis strains

Cannabis strains are named plant varieties, and the name tells you far less than most product pages suggest. A strain name is a marketing and breeding label, not a standardised formulation: two batches sold under the same name can differ in cannabinoid content, terpene profile and effect. What is measurable is the cannabinoid and terpene analysis of the specific batch in front of you. In South Africa, if you are considering cannabis strains for a medical reason, a registered doctor decides what is appropriate, not the strain name on the jar. Blackberry Kush is a useful worked example, and our page on that name sets out what the label does and does not tell you.

Last updated:

Key takeaways

  • A strain name is not a standardised product. The batch certificate of analysis is the part that carries real information.
  • Indica and sativa describe plant shape and growing history far better than they describe effects in a person.
  • The strongest clinical evidence for cannabis does not come from named strains. In the 2018 Cochrane review of cannabis based medicines for chronic neuropathic pain, 10 of the 16 included studies used a standardised oromucosal spray and only two used inhaled herbal cannabis.
  • The 2017 National Academies review found conclusive or substantial evidence for chronic pain in adults, and moderate evidence for short term sleep outcomes in specific conditions, again largely from standardised cannabinoid medicines.
  • In South Africa, access to THC containing cannabis runs through regulated channels, including a registered private members club, and prescribed cannabis medicines via a doctor.

What a strain name actually tells you

A strain name identifies a genetic line and a breeder’s story about it. It does not guarantee a chemical profile. The same genetics grown in different conditions, harvested at a different point, dried differently and stored for a different length of time will test differently, and that variation is not small. This is why clinicians and pharmacists talk about cannabinoid ratios and batch analyses rather than names.

Treat these varieties the way you would treat any other agricultural product where the active content matters. The useful questions are what the batch contains, who tested it, and when. The name is a starting point for a conversation, not an answer.

Indica, sativa and hybrid: useful shorthand, poor pharmacology

The indica and sativa split began as a botanical and agronomic distinction, describing plant structure and growing origin. It was later adopted by the consumer market as a shorthand for effect, with indica framed as relaxing and sativa as energising. That shorthand persists because it is easy to remember, not because plant shape predicts what a given batch will do in a given person.

Modern commercial cannabis is also overwhelmingly hybridised, so the labels have drifted further from anything botanically clean. Chemical analysis is the honest replacement: what cannabinoids are present, in what ratio, alongside which terpenes. Two products both labelled indica can differ more from each other than one of them differs from a sativa labelled batch.

Where those two words came from, and why South African scheduling ignores them entirely, is set out in our guide to sativa vs indica in South Africa.

Close-up of cannabis leaves and bud, the plant behind the cannabis strains people compare

Terpenes and the entourage idea

Terpenes are the aromatic compounds that give each variety its smell, and they appear throughout the plant kingdom. Limonene is the citrus note in citrus peel, pinene the resinous note in pine, myrcene a herbal note found in hops and mango, linalool the floral note in lavender. The entourage effect is the proposal that cannabinoids and terpenes together produce something different from any of them alone.

It is a plausible and much discussed idea, and it is not the same thing as a demonstrated clinical result. Terpene content is real and measurable; the claim that a particular terpene profile reliably produces a particular effect in patients is not established to the standard of the cannabinoid evidence below. Read terpene marketing as a description of aroma and a hypothesis about effect, not as a proven mechanism.

What the evidence on cannabis actually supports

The most useful summary remains the 2017 National Academies of Sciences, Engineering, and Medicine review of the health effects of cannabis and cannabinoids. Its first therapeutic conclusion states that there is conclusive or substantial evidence that cannabis is effective for the treatment of chronic pain in adults. It also lists moderate evidence for improving short term sleep outcomes in people with sleep disturbance associated with obstructive sleep apnoea syndrome, fibromyalgia, chronic pain and multiple sclerosis, mainly from standardised cannabinoid medicines rather than herbal material.

The 2018 Cochrane review of cannabis based medicines for chronic neuropathic pain in adults is more cautious. Across 16 studies and 1,750 participants, 21 percent of people on a cannabis based medicine reported at least 50 percent pain relief compared with 17 percent on placebo, which the authors rated low quality evidence, while withdrawals for adverse events ran at 10 percent versus 5 percent. The detail that matters most for anyone shopping by strain name is what was actually studied: 10 of the 16 trials used a standardised THC and CBD oromucosal spray and only two used inhaled herbal cannabis.

The two reviews are not in conflict. They asked different questions, one about chronic pain broadly and one about chronic neuropathic pain specifically. Together they support a modest, real, condition specific role for cannabinoid medicines and give no basis at all for claiming that a named strain treats a named condition.

Cannabis strains and sleep

Sleep is where strain marketing is at its loudest and the evidence at its narrowest. Moderate evidence for short term sleep outcomes, in the specific populations the National Academies listed, is a genuine finding and a limited one. It says nothing about long term use in an otherwise healthy adult with insomnia, and it does not come from the indica strain names attached to sleep claims in retail listings.

If sleep is the reason you are researching cannabis strains, the productive step is a conversation with a doctor about what is actually causing the disturbance. Insomnia has causes that respond to specific treatment, and some of them get worse if they are masked. That is a clinical assessment, not a shopping decision.

Before you start

In South Africa, access to cannabis containing THC runs through regulated channels, including a registered private members club, and prescribed medicines via a registered doctor. This article is general information for adults 18 and over and is not medical advice, and it does not recommend an amount, a product or a schedule for anyone. Cannabinoids can interact with other medicines, so speak to a doctor or pharmacist before starting, stopping or changing any treatment, and take questions about how much and how often to them rather than to a product listing.

Why the same name is not the same product twice

Cultivation conditions, harvest timing, drying, curing and storage all move the final chemistry, and the market that sells them has a documented labelling problem. In a 2017 JAMA analysis of 84 cannabidiol products bought online from 31 companies, fewer than a third were accurately labelled, roughly 43 percent contained more CBD than stated and about 26 percent contained less, and THC was detected in 18 of the 84 samples. That study looked at CBD extracts rather than flower, but it makes the general point: without independent testing, the label is a claim, not a measurement.

What to ask for is the same everywhere. A recent certificate of analysis from an independent laboratory, cannabinoid content stated per unit, a batch number that matches the product in your hand, and a supplier willing to answer where the material came from. A product with paperwork beats a famous name without it, every time.

Scientist examining plant samples in a laboratory, the batch testing that matters more than strain names

Cannabis strains and South African law

Two separate legal tracks apply, and confusing them is the most common mistake in this subject. Under the Cannabis for Private Purposes Act 7 of 2024, an adult may use, possess and cultivate cannabis for a private purpose, concealed from public view, and may provide it to or obtain it from another adult without payment in a private place. Use in a public place is not permitted, and dealing remains an offence carrying a fine or up to ten years imprisonment. There is no personal cannabis permit in South African law, whatever some older articles claim.

The medical track is different. THC is tightly scheduled under the medicines schedules, and cannabidiol sits in Schedule 4 with narrow low dose exceptions that fall to Schedule 0. A cannabis medicine that is not registered in South Africa can still be accessed, but through a Section 21 authorisation that an authorised prescriber applies for on a named patient basis. Patients do not apply for themselves, and no retailer can substitute for that process.

How Professor Green fits into the process

Professor Green is a South African medical cannabis platform. Registering creates your account and gives you access to the member area, where you can see what the platform offers and continue through the access process. That is what registration provides, and nothing more is implied by it.

Professor Green does not diagnose, does not prescribe and does not decide what suits you. A registered doctor assesses you and, where a cannabis medicine is appropriate and unregistered in South Africa, applies to SAHPRA under Section 21. A licensed pharmacy dispenses, and the pharmacy or a courier handles delivery. Professor Green is a marketing affiliate for the Dr Green network. Registration submits to the Dr Green DApp on the blockchain, and Dr Green runs the members store. Professor Green holds no customer data. Registration is a next step, not a guarantee of eligibility, stock, a prescription or an outcome. If you want the medical background first, our guides to sublingual cannabis and to who decides cannabis oil dosage in South Africa cover the parts that actually change what you receive.

Frequently asked questions about cannabis strains

Do cannabis strains really have different effects?
Different batches genuinely differ in cannabinoid and terpene content, and that chemistry can produce different experiences. What is not reliable is the strain name as a predictor, because the same name can be grown and processed to very different chemical profiles. The batch analysis is the informative part.

Is indica actually more relaxing than sativa?
The indica and sativa labels describe plant structure and growing origin rather than pharmacology, and most commercial cannabis is hybridised. Two products labelled indica can differ more from each other than from a sativa labelled batch, so treat the label as shorthand rather than as a prediction.

Which cannabis strain is best for pain?
No strain can honestly be named as best for pain. The 2017 National Academies review found conclusive or substantial evidence that cannabis is effective for chronic pain in adults, but the trials behind the cannabinoid evidence largely used standardised medicines, not named strains. In South Africa a prescriber decides what is appropriate for you.

Do terpenes change how a variety affects you?
Terpenes are real, measurable aroma compounds, and the entourage effect proposes that they work together with cannabinoids. It remains a hypothesis rather than a clinically established mechanism, so terpene profiles are best read as a description of aroma and character.

Is cannabis legal in South Africa?
Under the Cannabis for Private Purposes Act 7 of 2024 an adult may use, possess and cultivate cannabis for a private purpose, concealed from public view, while use in a public place is not permitted and dealing remains an offence. Prescribed cannabis medicines containing THC are a separate matter and run through a doctor.

Is there a cannabis permit for personal use in South Africa?
No. There is no personal cannabis permit in South African law. Licences and permits issued by SAHPRA cover activities such as cultivation, manufacture, import and wholesale by licensed operators, not private use by an individual.

How do I know a product matches the strain on the label?
Ask for a recent certificate of analysis from an independent laboratory, with a batch number matching the product in your hand and cannabinoid content stated per unit. Labelling accuracy has been a documented problem in cannabis derived products, so documentation matters more than the name.

Can my doctor prescribe specific cannabis strains?
A prescriber works with cannabis medicines and their cannabinoid profiles rather than consumer strain names, and where the medicine is unregistered in South Africa they apply to SAHPRA under Section 21 on a named patient basis. Bring your goals and your full medicine list to that appointment.

The bottom line on cannabis strains

Cannabis strains are a useful vocabulary for talking about plant lineage and aroma, and a weak basis for a health decision. The names are not standardised, the indica and sativa shorthand does not describe pharmacology, and the clinical evidence that does exist was mostly generated with standardised cannabinoid medicines rather than the varieties sold by name. Read the batch analysis, treat terpene marketing as description rather than proof, and if your reason for researching this is medical, take it to a registered doctor who can assess you and, where appropriate, apply for access under Section 21. For a related comparison of formats rather than varieties, see our guide to CBD capsules versus oil, and for a lesser known cannabinoid, CBDV in South Africa.

Want to explore legal medical cannabis access in South Africa?

If researching cannabis strains has led you towards the medical route, the next step is to create an account and see how Professor Green works. Registration starts the store access process. It is not a guarantee of eligibility, stock or a prescription, and any cannabis medicine still comes through a registered doctor and a licensed pharmacy.

Register for Store Access

Sources and references

  • National Academies of Sciences, Engineering, and Medicine, The Health Effects of Cannabis and Cannabinoids (2017), report conclusions 4-1 and 4-19. nap.nationalacademies.org
  • Mucke M and others, Cannabis based medicines for chronic neuropathic pain in adults, Cochrane Database of Systematic Reviews, 2018. PMC6494210
  • Bonn-Miller MO and others, Labeling Accuracy of Cannabidiol Extracts Sold Online, JAMA, 2017. PMC5818782
  • Cannabis for Private Purposes Act 7 of 2024, Government Gazette 50744, 3 June 2024. parliament.gov.za
  • SAHPRA, Section 21 access to unregistered medicines. sahpra.org.za/section-21
  • SAHPRA, Communication to industry: scheduling status of THC and CBD (Government Notice 586, Government Gazette 43347, 22 May 2020). sahpra.org.za
  • SAHPRA, Licences and permits issued under section 22C of the Medicines and Related Substances Act 101 of 1965. sahpra.org.za/licences

This article is general information for adults 18 and over in South Africa and is not medical advice. It does not claim that cannabis or any cannabis strain treats, cures or prevents any disease, and it does not recommend an amount or a schedule. Speak to a registered doctor or pharmacist about your own situation before starting, stopping or changing any treatment.

Buy cannabis in South Africa in South Africa

Professor Green is a marketing affiliate for the Dr Green network, which runs a private medical cannabis members club for adults across South Africa. You do not need a prescription. Register with your details and a home address that matches your South African ID card, driver’s licence or passport, and the form submits to the Dr Green DApp on the blockchain, where verification happens. Once Dr Green approves you, you can order from the Dr Green members store.

Delivery in Johannesburg and Cape Town

Members order for delivery across Johannesburg, including Sandton, Bryanston, Rosebank, Hyde Park, Parkhurst, Houghton Estate, Bedfordview, Fourways and Melrose Arch. In Cape Town we deliver to Camps Bay, Clifton, Bantry Bay, Sea Point, Green Point, Constantia, Bishopscourt, Fresnaye and the Atlantic Seaboard.

Apply for membership

Do I need a prescription to join Professor Green?

No. Professor Green is a marketing affiliate for the Dr Green network, which runs the members club. You register with your details and a home address matching your South African ID card, driver’s licence or passport, and once Dr Green has approved you, you can order from the Dr Green members store.

Does Professor Green deliver in Johannesburg and Cape Town?

Yes. Members receive delivery across Johannesburg and Cape Town, and across the rest of South Africa, to the address registered on their account.

Share the Post:

Related Posts

Professorgreen.co.za is ran by Green Tec LLC is an authorised marketing affiliate for the Dr Green network who holds the Medical Cannabis licences in South Africa. We do not sell, handle, or ship cannabis. All cannabis products are sold and fulfilled by licensed operator DR Green.

Our Social